Akt, AS160, metabolic risk factors and aerobic fitness in middle-aged women

Exercise Immunology Review

Volumn 16, Issue , 2010, Pages 98-104

  Levinger, Itamar ^a   Howlett, Kirsten F ^b   Peake, Jonathan ^c   Garnham, Andrew ^b   Hare, David L ^d   Jerums, George ^d   Selig, Steve ^a   Goodman, Craig ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aerobic fitness; Cytokines; Inflammation; Insulin signaling

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN AS160; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; TBC1D4 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADULT; AEROBIC CAPACITY; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MULTIPLE REGRESSION; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN PHOSPHORYLATION; VENOUS OXYGEN TENSION; BLOOD; BLOOD PRESSURE; FITNESS; GLUCOSE BLOOD LEVEL; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RISK FACTOR; SKELETAL MUSCLE; WAIST CIRCUMFERENCE; WESTERN BLOTTING;

BLOOD GLUCOSE; BLOOD PRESSURE; BLOTTING, WESTERN; FEMALE; GTPASE-ACTIVATING PROTEINS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPOPROTEINS, HDL; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHORYLATION; PHYSICAL FITNESS; PROTO-ONCOGENE PROTEINS C-AKT; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 77957968852     PISSN: 10775552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ACSM. Exercise and type 2 diabetes: position stand of the American College of Sports Medicine. Med Sci Sports Exerc 32: 1345-1360, 2000.
2. Arsenault BJ, Cartier A, Cote M, Lemieux I, Tremblay A, Bouchard C, Perusse L, and Despres JP. Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women. Am J Cardiol 104: 240-246, 2009.
3. Bouzakri K, and Zierath JR. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. J Biol Chem 282: 7783-7789, 2007. (Pubitemid 47093599)
4. Cartee GD, andWojtaszewski JF. Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. Appl Physiol Nut Metabol 32: 557-566, 2007.
5. D'Alessandris C, Lauro R, Presta I, and Sesti G. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia 50: 840-849, 2007. (Pubitemid 46355815)
6. Drew BG, Duffy SJ, Formosa MF, Natoli AK, Henstridge DC, Penfold SA, Thomas WG, Mukhamedova N, de Courten B, Forbes JM, Yap FY, Kaye DM, van Hall G, Febbraio MA, Kemp BE, Sviridov D, Steinberg GR, and Kingwell BA. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 119: 2103-2111, 2009.
7. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, and Heiss G. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52: 1799-1805, 2003. (Pubitemid 36792473)
8. Evans WJ, Phinney SK, and Young VR. Suction applied to a muscle biopsy maximizes sample size. Med Sci Sports Exerc 14: 101-102, 1982. (Pubitemid 12118274)
9. Haffner SM, Kennedy E, Gonzalez C, Stern MP, and Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 19: 1138-1141, 1996. (Pubitemid 26334266)
10. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, and Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271: 665-668, 1996. (Pubitemid 26052915)
11. Kanety H, Feinstein R, Papa MZ, Hemi R, and Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Bio Chem 270: 23780-23784, 1995.
12. Karlsson HK, Zierath JR, Kane S, Krook A, Lienhard GE, and Wallberg-Henriksson H. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 54: 1692-1697, 2005. (Pubitemid 40770759)
13. Krook A, Roth RA, Jiang XJ, Zierath JR, and Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47: 1281-1286, 1998. (Pubitemid 28357006)
14. Krook A, Wallberg-Henriksson H, and Zierath JR. Sending the signal: molecular mechanisms regulating glucose uptake. Med Sci Sports Exerc 36: 1212-1217, 2004. (Pubitemid 38878998)
15. Levinger I, Goodman C, Hare DL, Jerums G, and Selig S. The effect of resistance training on functional capacity and quality of life in individuals with high and low numbers of metabolic risk factors. Diabet Care 30: 2205-2210, 2007. (Pubitemid 47359015)
16. Levinger I, Goodman C, Peake J, Garnham A, Hare DL, Jerums G, and Selig S. Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors. Diabet Med 26: 220-227, 2009.
17. Miller AP, Chen YF, Xing D, Feng W, and Oparil S. Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Hypertension 42: 657-663, 2003. (Pubitemid 37237305)
18. Zimmet PZ, Alberti KG, and Shaw JE. Mainstreaming the metabolic syndrome: a definitive definition. This new definition should assist both researchers and clinicians. Med J Aus 183: 175-176, 2005.